Description

The global DTC testing market is poised to grow by US$ 2,456.5 million during 2022-2028, progressing at a CAGR of 14.7% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for DTC testing. The global DTC testing market is segmented on the basis of type, distribution channel, application, and region. By type, the global DTC testing market has been segmented into biomarker-based tests, genetic tests, microbiome tests. The genetic tests segment was the largest contributor to the global DTC testing market in 2021. Based upon distribution channel, the global DTC testing market is categorized into online channel, retail channel. According to the research, the online channel segment had the largest share in the global DTC testing market. On the basis of application, the global DTC testing market has been segmented into ancestry and genealogy testing, carrier screening, disease risk assessment, health and wellness testing, others. The ancestry and genealogy testing segment held the largest revenue share in 2021. Geographically, the global DTC testing market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the DTC testing market.

The global DTC testing market is highly competitive. The leading players in the DTC testing market include Ancestry.com LLC, Dante Labs Inc., Everly Well Inc., Identigene L.L.C. (DNA Diagnostics Center Inc.), Karmagenes SA, Laboratory Corporation of America Holdings (Labcorp), Pathway Genomics Corporation, PrivaPath Diagnostics Limited, Psomagen Inc. Competitive landscape gives a description of the competitive nature of the global DTC testing market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the DTC testing market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: biomarker-based tests, genetic tests, microbiome tests
Distribution channel: online channel, retail channel
Application: ancestry and genealogy testing, carrier screening, disease risk assessment, health and wellness testing, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Ancestry.com LLC, Dante Labs Inc., Everly Well Inc., Identigene L.L.C. (DNA Diagnostics Center Inc.), Karmagenes SA, Laboratory Corporation of America Holdings (Labcorp), Pathway Genomics Corporation, PrivaPath Diagnostics Limited, Psomagen Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global DTC testing market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. DTC testing market overview
Part 3. Market breakdown by type
– Biomarker-based tests
– Genetic tests
– Microbiome tests
Part 4. Market breakdown by distribution channel
– Online channel
– Retail channel
Part 5. Market breakdown by application
– Ancestry and genealogy testing
– Carrier screening
– Disease risk assessment
– Health and wellness testing
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Ancestry.com LLC
– Dante Labs Inc.
– Everly Well, Inc.
– Identigene, L.L.C. (DNA Diagnostics Center, Inc.)
– Karmagenes SA
– Laboratory Corporation of America Holdings (Labcorp)
– Pathway Genomics Corporation
– PrivaPath Diagnostics Limited
– Psomagen, Inc.
About StrategyHelix
Disclaimer